Chemomab Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CMMB and other ETFs, options, and stocks.About CMMB
Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.
CEOAdi Mor
CEOAdi Mor
Employees16
Employees16
HeadquartersTel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded2011
Founded2011
Employees16
Employees16
CMMB Key Statistics
Market cap13.79M
Market cap13.79M
Price-Earnings ratio-1.19
Price-Earnings ratio-1.19
Dividend yield—
Dividend yield—
Average volume94.45K
Average volume94.45K
High today$2.57
High today$2.57
Low today$2.27
Low today$2.27
Open price$2.41
Open price$2.41
Volume16.55K
Volume16.55K
52 Week high$9.84
52 Week high$9.84
52 Week low$2.21
52 Week low$2.21
Stock Snapshot
With a market cap of 13.79M, Chemomab Therapeutics(CMMB) trades at $2.48. The stock has a price-to-earnings ratio of -1.19.
During the trading session on 2025-12-15, Chemomab Therapeutics(CMMB) shares reached a daily high of $2.57 and a low of $2.27. At a current price of $2.48, the stock is +9.3% higher than the low and still -3.5% under the high.
Trading volume for Chemomab Therapeutics(CMMB) stock has reached 16.55K, versus its average volume of 94.45K.
The stock's 52-week range extends from a low of $2.21 to a high of $9.84.
The stock's 52-week range extends from a low of $2.21 to a high of $9.84.